Literature DB >> 4563302

Effect of ICRF 159 on immune responses.

K Hellmann.   

Abstract

Mesh:

Substances:

Year:  1972        PMID: 4563302      PMCID: PMC1644020     

Source DB:  PubMed          Journal:  Proc R Soc Med        ISSN: 0035-9157


× No keyword cloud information.
  7 in total

1.  Effect of ICRF159 on the mammalian cell cycle: significance for its use in cancer chemotherapy.

Authors:  K Hellmann; E O Field
Journal:  J Natl Cancer Inst       Date:  1970-03       Impact factor: 13.506

2.  Control of malignant metastases by ICRF l59.

Authors:  K Hellmann; K Burrage
Journal:  Nature       Date:  1969-10-18       Impact factor: 49.962

3.  Mode of action of the cytostatic agent "ICRF 159".

Authors:  H B Sharpe; E O Field; K Hellmann
Journal:  Nature       Date:  1970-05-09       Impact factor: 49.962

4.  Inhibition of metastatic spread by I.C.R.F. 159: selective deletion of a malignant characteristic.

Authors:  A J Salsbury; K Burrage; K Hellmann
Journal:  Br Med J       Date:  1970-11-07

5.  Antitumour activity in a series of bisdiketopiperazines.

Authors:  A M Creighton; K Hellmann; S Whitecross
Journal:  Nature       Date:  1969-04-26       Impact factor: 49.962

6.  Tumour-specific antibodies in human malignant melanoma and their relationship to the extent of the disease.

Authors:  M G Lewis; R L Ikonopisov; R C Nairn; T M Phillips; G H Fairley; D C Bodenham; P Alexander
Journal:  Br Med J       Date:  1969-09-06

7.  Preliminary clinical assessment of I.C.R.F. 159 in acute leukaemia and lymphosarcoma.

Authors:  K Hellmann; K A Newton; D N Whitmore; I W Hanham; J V Bond
Journal:  Br Med J       Date:  1969-03-29
  7 in total
  3 in total

1.  Factors in tumour dissemination.

Authors:  D C Williams
Journal:  Proc R Soc Med       Date:  1974-09

2.  Combined treatment of the Walker tumour with radiotherapy and ICRF 159.

Authors:  K Norpoth; A Schaphaus; H Ziegler; U Witting
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1974

3.  Further studies on B-lymphocyte suppression in delayed hypersensitivity, indicating a possible mechanism for Jones-Mote hypersensitivity.

Authors:  J L Turk; D Parker
Journal:  Immunology       Date:  1973-04       Impact factor: 7.397

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.